Purchase Order AG32SCP150253
- Not listed
- This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $98,056.80 order is for Illumina kits with no set-aside designation. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal agencies including NIH, CDC, USDA, and VA. This...
- This is a firm fixed price delivery order awarded by the Department of Agriculture's Agricultural Research Service to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $14,410.94 award is for the purchasing of Illumina items through strategic sourcing, with no set-aside used. Illumina has previously provided sequencing systems, reagents, and services to support genomic research and diagnostics for various federal agencies, including...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $15,807.96 award provides Illumina's proprietary sequencing systems, reagents, and services to support nucleic acid sequencing needs, with no set-aside designation. The order is part of a larger Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery, valued up...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $113,164.34 order is for the provision of sequencing systems, consumables, and maintenance services to support the agency's research and diagnostic needs. Illumina has a history of providing similar products and services to federal agencies like the NIH, Centers for Disease Control, and Department of...
- This is a firm fixed price delivery order contract awarded to Illumina, Inc. by the National Institute on Aging, a civilian agency. The contract covers the provision of Illumina's RNA sequencing and DNA methylation kits, as well as flow cells, with a ceiling value of $142,386.33 and a period of performance through October 19, 2024. No set-aside designation was used for this award. Illumina is a manufacturer of genetic and genomic analysis instrumentation and reagents, and has a history of...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The contract, valued at $145,412.23, is for the provision of laboratory equipment, with no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies, including the National Institutes of Health,...
- This $111,697.92 firm fixed-price purchase order was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. for DNA analysis kits. The contract is not associated with a set-aside or larger contract vehicle. Illumina is a manufacturer of sequencing and array-based genomic analysis solutions, and has provided a range of sequencing instruments, reagents, and services to support research and...
- This firm fixed-price delivery order was awarded by the National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic sequencing systems and related products. The $115,493.42 award does not have a set-aside designation. Illumina has previously provided sequencing instruments, reagents, and services to support genomic research and analysis for various federal agencies like the NIH, Centers for Disease Control and Prevention,...
- This is a firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc. The order is for $75,832.10 and does not have a set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and consumables, is providing products and services to support genomic sequencing and analysis, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and bioinformatics support....
This is a firm fixed price purchase order awarded by the Northeast Area of the U.S. government's civilian agency to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $31,584.00 contract, which does not have a set-aside designation, is for the analysis of DNA methylation profiles. Illumina has previously provided a range of sequencing systems, consumables, and bioinformatics products to support genomic research and diagnostics at agencies like the NIH, CDC, USDA, and VA. This award appears to be part of a larger $3.3 million Indefinite Delivery Contract with the Department of the Navy's Bureau of Medicine and Surgery to support nucleic acid sequencing needs, including for characterizing biological threats at the Naval Medical Research Center.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.6k | 9/21/15 |